## CTAS: Cintas Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -1.9% below STRENGTH zone (4.0-10.0%); PEG 3.45 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($178.69)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Cintas (CTAS) Stock on December 2, 2025: Institutions Buy the Dip as Analysts See Mid‑Teens Upside**
- Source: ts2.tech | 20251203T005656 | Somewhat-Bullish | Relevance: 100%
- Cintas (CTAS) stock is trading around $184 per share as of December 2, 2025, down 16-17% over the last 12 months despite consistent high-single-digit revenue growth and expanding margins. Large asset managers are using this dip to accumulate shares, and Wall Street analysts project mid-teens upside for the stock over the next year. The company reported a Q1 FY26 earnings beat and raised its full-year guidance, alongside authorizing a new $1.0 billion share repurchase program.

**2. How Should Investors View Cintas After Analyst Upgrades and a 16% Yearly Drop?**
- Source: Simply Wall Street | 20251202T100644 | Somewhat-Bearish | Relevance: 100%
- Cintas has seen a 16.0% drop in its stock over the past year despite recent analyst upgrades and multi-year gains. Traditional valuation models, including Discounted Cash Flow (DCF) and Price-to-Earnings (PE) ratios, suggest the stock is currently overvalued, with a DCF analysis indicating a 12.8% overvaluation. Simply Wall St introduces "Narratives" as an alternative approach for investors to connect business strengths, risks, and forecasts to their fair value assessment for more personalized investment decisions.

**3. Cintas Stock (CTAS) on December 1, 2025: Price, Q1 2026 Earnings Beat, Dividend Hike and 2026–2028 Forecast**
- Source: ts2.tech | 20251202T000616 | Somewhat-Bullish | Relevance: 100%
- Cintas Corporation (NASDAQ: CTAS) experienced a modest pullback from record highs while still delivering a "beat and raise" Q1 FY 2026 earnings report, announcing a $1 billion share buyback, and extending its dividend growth streak. As of December 1, 2025, the stock trades around $185.43, below its June peak, with analysts predicting mid-teens upside over the next year and low-double-digit annualized returns through 2028, assuming continued strong execution despite valuation risks. The article details Cintas's financial performance, capital return strategy, and Wall Street forecasts, alongside potential risks.

**4. Westerkirk Capital Inc. Buys Shares of 7,000 Cintas Corporation $CTAS**
- Source: MarketBeat | 20251203T141406 | Somewhat-Bullish | Relevance: 100%
- Westerkirk Capital Inc. acquired a new position of 7,000 shares in Cintas Corporation (NASDAQ:CTAS) during Q2, valued at approximately $1.56 million. Cintas reported strong Q3 earnings, exceeding analyst expectations, and announced a new $1.00 billion share repurchase program and a quarterly dividend. Institutional investors now own about 63.46% of Cintas stock.

**5. Invesco Ltd. Grows Position in Cintas Corporation $CTAS**
- Source: MarketBeat | 20251203T103834 | Neutral | Relevance: 100%
- Invesco Ltd. significantly increased its stake in Cintas Corporation in the second quarter, purchasing an additional 495,486 shares to own a total of 4,911,366 shares valued at approximately $1.0946 billion. Other hedge funds also adjusted their positions in Cintas, and the company has authorized a $1.00 billion share buyback and declared a quarterly dividend of $0.45. Analysts currently rate Cintas as a "Hold" with an average price target of $212.71.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-25 | Wells Fargo | $185 | $218 | -15% |
| 2025-11-12 | Bernstein | $200 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-25 | Wells Fargo | main | Equal-Weight |
| 2025-11-12 | Bernstein | init | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 7 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 29.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.7% (+1.5%)
- Blackrock Inc.: 7.2% (+2.1%)
- State Street Corpora: 3.8% (-0.1%)
- Geode Capital Manage: 2.3% (+0.1%)
- FMR, LLC: 2.2% (-10.1%)

### Key Risks

1. Valuation stretched: PEG 3.4x requires aggressive growth execution.
2. Long-term trend broken: trading 10.6% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.45 signals overvaluation risk, limited margin of safety. Forward P/E 34.2x stretched relative to 11% growth. Quality metrics strong (ROE 43%, ROA 16%, margin 18%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $77.0B |
| Beta | 0.96 |
| 52W Range | $180.39 - $229.24 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.45 |
| Forward P/E | 34.2 |
| Current P/E | 37.9 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -0.5% to -1.9% (-1.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.9pp (needs >4.0% for momentum thesis). Below SMA200 (0.89x), long-term trend not supportive. RSI neutral at 46. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.89% (CS: 32) | Neutral |
| RSI_14 | 45.7 | Neutral |
| MACD Histogram | 0.49 | Bullish |
| vs SMA20 | 0.999x | Below |
| vs SMA50 | 0.973x | Below |
| vs SMA200 | 0.894x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $184.71
- **Stop Loss:** $178.69 (3.3% risk)
- **Target:** $190.73 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 157
- **Position Value:** $28,999.47
- **Portfolio %:** 29.00%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2025-12-18 (Est: $1.20)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.19 | $1.21 | +1.3% |
| 2025Q3 | $1.20 | $1.20 | +0.3% |
| 2025Q2 | $1.07 | $1.09 | +1.9% |
| 2025Q1 | $1.06 | $1.13 | +7.1% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*